Curing Social Distance Fatigue

Prognosis: Misconception

Bloomberg

Health & Fitness, Science

4.1 • 838 Ratings

🗓️ 22 May 2020

⏱️ 15 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

There’s a growing public health argument about how people should calculate risk when it comes to social distancing. Many states are now lifting stay-at-home restrictions, summer is around the corner, and people in the third month of what many hoped would be a weeks-long disruption are desperate to visit friends and get outside. That means we will be socializing a lot more--in many cases, without clear guidelines as to what’s really risky. Kristen V. Brown reports that as we learn more about how the virus spreads, and what constitutes risky behavior, messaging from experts will have to become a little more nuanced than just “stay home, stay safe.”

See omnystudio.com/listener for privacy information.

Transcript

Click on a timestamp to play from that location

0:00.0	What could you do if your data was working for you and not against you? With Bloomberg delivering
0:07.3	enterprise data directly to your systems, you get easy access to the details you want, optimized for
0:14.1	higher level analysis, and financial data experts committed to helping you maximize your every move.
0:21.1	Our data is made for more, so you can show the world what you're made of.
0:26.6	Visit Bloomberg.com slash enterprise data to learn more.
0:33.6	Welcome to Prognosis. I'm Laura Carlson.
0:41.5	It's day 72 since coronavirus was declared a global pandemic.
0:46.6	Our main story?
0:48.3	When lockdown measures went into effect in countries around the world,
0:52.3	many expected to be trapped at home for a few weeks.
0:56.3	But months into the pandemic, people are now looking for a way to make social distancing
1:02.0	sustainable, while tentatively returning to some of their old activities. State and local governments
1:08.3	are having a hard time helping people navigate those gray areas,
1:12.4	because there are few clear answers.
1:16.6	But first, here's what happened today.
1:27.2	Yet another study is showing the dangers of anti-malaria drugs touted by U.S. President Donald Trump for treating COVID-19.
1:35.3	Hydroxychloroquine and chloroquine were linked to an increased risk of death and heart ailments.
1:42.3	The drugs don't benefit patients with the coronavirus either alone
1:45.8	or in combination with other drugs, according to a study published today by the Lancet Medical
1:51.4	Journal. Trump's endorsement has led many people to take the medications without scientific proof
1:58.0	of their benefit. An experimental vaccine developed by Chinese company Kansino Biologics is showing promise.
2:06.2	An early study shows that the vaccine was safe and generated an immune response.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Bloomberg, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Bloomberg and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.